瑞米唑仑：敲响警钟，让我们保持警惕。 - Suppr

Suppr

超能文献

Remimazolam: a new reminder to keep our guard up.

作者信息

Abad-Gurumeta Alfredo, Gómez-Ríos Manuel A

机构信息

Department of Anaesthesiology and Perioperative Medicine, Infanta Leonor University Hospital, Madrid, Spain -

Department of Pharmacology, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain -

出版信息

Minerva Anestesiol. 2023 Jun;89(6):495-497. doi: 10.23736/S0375-9393.23.17321-4. Epub 2023 May 9.

DOI:10.23736/S0375-9393.23.17321-4

PMID:37158630

Abstract

摘要

相似文献

Remimazolam: a new reminder to keep our guard up.

Minerva Anestesiol. 2023 Jun;89(6):495-497. doi: 10.23736/S0375-9393.23.17321-4. Epub 2023 May 9.

Remimazolam for anaesthesia or sedation.

Curr Opin Anaesthesiol. 2020 Aug;33(4):506-511. doi: 10.1097/ACO.0000000000000877.

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.

Gastrointest Endosc. 2018 Sep;88(3):427-437.e6. doi: 10.1016/j.gie.2018.04.2351. Epub 2018 Apr 30.

Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.

Curr Med Res Opin. 2023 May;39(5):691-699. doi: 10.1080/03007995.2023.2196198. Epub 2023 Apr 11.

Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study.

Chin Med J (Engl). 2022 Sep 5;135(17):2134-2136. doi: 10.1097/CM9.0000000000002243.

A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam.

Eur J Pharmacol. 2021 Apr 5;896:173886. doi: 10.1016/j.ejphar.2021.173886. Epub 2021 Jan 23.

A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.

Anesth Analg. 2012 Aug;115(2):274-83. doi: 10.1213/ANE.0b013e31823f0c28. Epub 2011 Dec 20.

Remimazolam (Byfavo) for short-term procedural sedation.

Med Lett Drugs Ther. 2022 Feb 21;64(1644):26-28.

A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.

Anesth Analg. 2012 Aug;115(2):284-96. doi: 10.1213/ANE.0b013e318241f68a. Epub 2012 Jan 16.

Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.

Eur J Clin Pharmacol. 2020 Mar;76(3):383-391. doi: 10.1007/s00228-019-02800-3. Epub 2019 Dec 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Remimazolam: a new reminder to keep our guard up.

作者信息

Abad-Gurumeta Alfredo, Gómez-Ríos Manuel A

机构信息

Department of Anaesthesiology and Perioperative Medicine, Infanta Leonor University Hospital, Madrid, Spain -

Department of Pharmacology, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain -

出版信息

Minerva Anestesiol. 2023 Jun;89(6):495-497. doi: 10.23736/S0375-9393.23.17321-4. Epub 2023 May 9.

DOI:10.23736/S0375-9393.23.17321-4

PMID:37158630

Abstract

摘要

相似文献

Remimazolam: a new reminder to keep our guard up.

Minerva Anestesiol. 2023 Jun;89(6):495-497. doi: 10.23736/S0375-9393.23.17321-4. Epub 2023 May 9.

Remimazolam for anaesthesia or sedation.

Curr Opin Anaesthesiol. 2020 Aug;33(4):506-511. doi: 10.1097/ACO.0000000000000877.

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.

Gastrointest Endosc. 2018 Sep;88(3):427-437.e6. doi: 10.1016/j.gie.2018.04.2351. Epub 2018 Apr 30.

Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.

Curr Med Res Opin. 2023 May;39(5):691-699. doi: 10.1080/03007995.2023.2196198. Epub 2023 Apr 11.

Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study.

Chin Med J (Engl). 2022 Sep 5;135(17):2134-2136. doi: 10.1097/CM9.0000000000002243.

A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam.

Eur J Pharmacol. 2021 Apr 5;896:173886. doi: 10.1016/j.ejphar.2021.173886. Epub 2021 Jan 23.

Anesth Analg. 2012 Aug;115(2):274-83. doi: 10.1213/ANE.0b013e31823f0c28. Epub 2011 Dec 20.

Remimazolam (Byfavo) for short-term procedural sedation.

Med Lett Drugs Ther. 2022 Feb 21;64(1644):26-28.

Anesth Analg. 2012 Aug;115(2):284-96. doi: 10.1213/ANE.0b013e318241f68a. Epub 2012 Jan 16.

Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.

Eur J Clin Pharmacol. 2020 Mar;76(3):383-391. doi: 10.1007/s00228-019-02800-3. Epub 2019 Dec 23.